The global Cell Therapy CDMO Services market size is predicted to grow from US$ 2278 million in 2025 to US$ 7433 million in 2031; it is expected to grow at a CAGR of 21.8% from 2025 to 2031.
Cell therapy refers to the transfer of new cells, or cells that have been modified in a laboratory to achieve particular characteristics, into the body to prevent or treat a disease. A Contract Development and Manufacturing Organization (CDMO) is a company that provides comprehensive services to pharmaceutical, biotechnology, and medical device companies. CDMOs offer contract services for product development, formulation, manufacturing, packaging, and distribution. Contract development and manufacturing organizations (CDMOs) play a vital role in cell therapy development by offering crucial infrastructure and expertise.This report mainly focuses on cell therapy CDMO services market.
The cell therapy CDMO market is mainly concentrated in the following regions: North America (especially the United States) is the leader in the global cell therapy CDMO market, with advanced technology, a sound regulatory system and a large number of biopharmaceutical companies. The active support of the US FDA for cell therapy has also driven the growth of the market in the region. The European market also performed strongly, mainly due to the EU's support for cell therapy research and development and the regulatory framework of the EMA (European Medicines Agency). The United Kingdom, Germany and Switzerland are the main markets in Europe. The Asia-Pacific region (especially China, Japan and South Korea) is one of the fastest growing markets. The Chinese government's policy support and financial investment in the field of cell therapy, as well as Japan's leading position in regenerative medicine, have driven the rapid development of the market in the region. The markets in Latin America and the Middle East are relatively small, but with the popularization of cell therapy technology and the improvement of medical infrastructure, the market potential in these regions is gradually being released.
Challenges and Opportunities:
Challenges: The manufacturing process of cell therapy products is complex, requires high quality control, and is expensive. In addition, the instability of the global supply chain and the shortage of raw materials may also affect the delivery of CDMO services. Opportunities: With the advancement of technology and the optimization of manufacturing processes, CDMO companies have the opportunity to further expand their market share by providing efficient and low-cost services. In addition, the rise of emerging markets and the growing demand for personalized medicine have also provided new growth points for CDMO companies.
The 鈥淐ell Therapy CDMO Services Industry Forecast鈥� looks at past sales and reviews total world Cell Therapy CDMO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Therapy CDMO Services sales for 2025 through 2031. With Cell Therapy CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Cell Therapy CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Preclinical Stage
Clinical Commercialization Stage
Segmentation by Application:
Pharmaceutical Company
Research Institute
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
AGC Biologics
FUJIFILM Cellular Dynamics
Thermo Fisher Scientific
Wuxi AppTec
Lonza
KBI Biopharma
RoslinCT
Cell and Gene Therapy Catapult
Cell Therapies
Minaris Regenerative Medicine
MEDINET
Catalent Biologics
Oxford BioMedica
GenScript
Cell-Easy
SK pharmteco
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell Therapy CDMO Services Market Size (2020-2031)
2.1.2 Cell Therapy CDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Cell Therapy CDMO Services by Country/Region (2020, 2024 & 2031)
2.2 Cell Therapy CDMO Services Segment by Type
2.2.1 Preclinical Stage
2.2.2 Clinical Commercialization Stage
2.3 Cell Therapy CDMO Services Market Size by Type
2.3.1 Cell Therapy CDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Cell Therapy CDMO Services Market Size Market Share by Type (2020-2025)
2.4 Cell Therapy CDMO Services Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Research Institute
2.5 Cell Therapy CDMO Services Market Size by Application
2.5.1 Cell Therapy CDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Cell Therapy CDMO Services Market Size Market Share by Application (2020-2025)
3 Cell Therapy CDMO Services Market Size by Player
3.1 Cell Therapy CDMO Services Market Size Market Share by Player
3.1.1 Global Cell Therapy CDMO Services Revenue by Player (2020-2025)
3.1.2 Global Cell Therapy CDMO Services Revenue Market Share by Player (2020-2025)
3.2 Global Cell Therapy CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell Therapy CDMO Services by Region
4.1 Cell Therapy CDMO Services Market Size by Region (2020-2025)
4.2 Global Cell Therapy CDMO Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cell Therapy CDMO Services Market Size Growth (2020-2025)
4.4 APAC Cell Therapy CDMO Services Market Size Growth (2020-2025)
4.5 Europe Cell Therapy CDMO Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Cell Therapy CDMO Services Market Size Growth (2020-2025)
5 Americas
5.1 Americas Cell Therapy CDMO Services Market Size by Country (2020-2025)
5.2 Americas Cell Therapy CDMO Services Market Size by Type (2020-2025)
5.3 Americas Cell Therapy CDMO Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy CDMO Services Market Size by Region (2020-2025)
6.2 APAC Cell Therapy CDMO Services Market Size by Type (2020-2025)
6.3 APAC Cell Therapy CDMO Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell Therapy CDMO Services Market Size by Country (2020-2025)
7.2 Europe Cell Therapy CDMO Services Market Size by Type (2020-2025)
7.3 Europe Cell Therapy CDMO Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell Therapy CDMO Services by Region (2020-2025)
8.2 Middle East & Africa Cell Therapy CDMO Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Cell Therapy CDMO Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cell Therapy CDMO Services Market Forecast
10.1 Global Cell Therapy CDMO Services Forecast by Region (2026-2031)
10.1.1 Global Cell Therapy CDMO Services Forecast by Region (2026-2031)
10.1.2 Americas Cell Therapy CDMO Services Forecast
10.1.3 APAC Cell Therapy CDMO Services Forecast
10.1.4 Europe Cell Therapy CDMO Services Forecast
10.1.5 Middle East & Africa Cell Therapy CDMO Services Forecast
10.2 Americas Cell Therapy CDMO Services Forecast by Country (2026-2031)
10.2.1 United States Market Cell Therapy CDMO Services Forecast
10.2.2 Canada Market Cell Therapy CDMO Services Forecast
10.2.3 Mexico Market Cell Therapy CDMO Services Forecast
10.2.4 Brazil Market Cell Therapy CDMO Services Forecast
10.3 APAC Cell Therapy CDMO Services Forecast by Region (2026-2031)
10.3.1 China Cell Therapy CDMO Services Market Forecast
10.3.2 Japan Market Cell Therapy CDMO Services Forecast
10.3.3 Korea Market Cell Therapy CDMO Services Forecast
10.3.4 Southeast Asia Market Cell Therapy CDMO Services Forecast
10.3.5 India Market Cell Therapy CDMO Services Forecast
10.3.6 Australia Market Cell Therapy CDMO Services Forecast
10.4 Europe Cell Therapy CDMO Services Forecast by Country (2026-2031)
10.4.1 Germany Market Cell Therapy CDMO Services Forecast
10.4.2 France Market Cell Therapy CDMO Services Forecast
10.4.3 UK Market Cell Therapy CDMO Services Forecast
10.4.4 Italy Market Cell Therapy CDMO Services Forecast
10.4.5 Russia Market Cell Therapy CDMO Services Forecast
10.5 Middle East & Africa Cell Therapy CDMO Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Cell Therapy CDMO Services Forecast
10.5.2 South Africa Market Cell Therapy CDMO Services Forecast
10.5.3 Israel Market Cell Therapy CDMO Services Forecast
10.5.4 Turkey Market Cell Therapy CDMO Services Forecast
10.6 Global Cell Therapy CDMO Services Forecast by Type (2026-2031)
10.7 Global Cell Therapy CDMO Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Cell Therapy CDMO Services Forecast
11 Key Players Analysis
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Information
11.1.2 Charles River Laboratories Cell Therapy CDMO Services Product Offered
11.1.3 Charles River Laboratories Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Charles River Laboratories Main Business Overview
11.1.5 Charles River Laboratories Latest Developments
11.2 AGC Biologics
11.2.1 AGC Biologics Company Information
11.2.2 AGC Biologics Cell Therapy CDMO Services Product Offered
11.2.3 AGC Biologics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AGC Biologics Main Business Overview
11.2.5 AGC Biologics Latest Developments
11.3 FUJIFILM Cellular Dynamics
11.3.1 FUJIFILM Cellular Dynamics Company Information
11.3.2 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Offered
11.3.3 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 FUJIFILM Cellular Dynamics Main Business Overview
11.3.5 FUJIFILM Cellular Dynamics Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Cell Therapy CDMO Services Product Offered
11.4.3 Thermo Fisher Scientific Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Wuxi AppTec
11.5.1 Wuxi AppTec Company Information
11.5.2 Wuxi AppTec Cell Therapy CDMO Services Product Offered
11.5.3 Wuxi AppTec Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Wuxi AppTec Main Business Overview
11.5.5 Wuxi AppTec Latest Developments
11.6 Lonza
11.6.1 Lonza Company Information
11.6.2 Lonza Cell Therapy CDMO Services Product Offered
11.6.3 Lonza Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Lonza Main Business Overview
11.6.5 Lonza Latest Developments
11.7 KBI Biopharma
11.7.1 KBI Biopharma Company Information
11.7.2 KBI Biopharma Cell Therapy CDMO Services Product Offered
11.7.3 KBI Biopharma Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 KBI Biopharma Main Business Overview
11.7.5 KBI Biopharma Latest Developments
11.8 RoslinCT
11.8.1 RoslinCT Company Information
11.8.2 RoslinCT Cell Therapy CDMO Services Product Offered
11.8.3 RoslinCT Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 RoslinCT Main Business Overview
11.8.5 RoslinCT Latest Developments
11.9 Cell and Gene Therapy Catapult
11.9.1 Cell and Gene Therapy Catapult Company Information
11.9.2 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Offered
11.9.3 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Cell and Gene Therapy Catapult Main Business Overview
11.9.5 Cell and Gene Therapy Catapult Latest Developments
11.10 Cell Therapies
11.10.1 Cell Therapies Company Information
11.10.2 Cell Therapies Cell Therapy CDMO Services Product Offered
11.10.3 Cell Therapies Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Cell Therapies Main Business Overview
11.10.5 Cell Therapies Latest Developments
11.11 Minaris Regenerative Medicine
11.11.1 Minaris Regenerative Medicine Company Information
11.11.2 Minaris Regenerative Medicine Cell Therapy CDMO Services Product Offered
11.11.3 Minaris Regenerative Medicine Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Minaris Regenerative Medicine Main Business Overview
11.11.5 Minaris Regenerative Medicine Latest Developments
11.12 MEDINET
11.12.1 MEDINET Company Information
11.12.2 MEDINET Cell Therapy CDMO Services Product Offered
11.12.3 MEDINET Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 MEDINET Main Business Overview
11.12.5 MEDINET Latest Developments
11.13 Catalent Biologics
11.13.1 Catalent Biologics Company Information
11.13.2 Catalent Biologics Cell Therapy CDMO Services Product Offered
11.13.3 Catalent Biologics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Catalent Biologics Main Business Overview
11.13.5 Catalent Biologics Latest Developments
11.14 Oxford BioMedica
11.14.1 Oxford BioMedica Company Information
11.14.2 Oxford BioMedica Cell Therapy CDMO Services Product Offered
11.14.3 Oxford BioMedica Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Oxford BioMedica Main Business Overview
11.14.5 Oxford BioMedica Latest Developments
11.15 GenScript
11.15.1 GenScript Company Information
11.15.2 GenScript Cell Therapy CDMO Services Product Offered
11.15.3 GenScript Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 GenScript Main Business Overview
11.15.5 GenScript Latest Developments
11.16 Cell-Easy
11.16.1 Cell-Easy Company Information
11.16.2 Cell-Easy Cell Therapy CDMO Services Product Offered
11.16.3 Cell-Easy Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Cell-Easy Main Business Overview
11.16.5 Cell-Easy Latest Developments
11.17 SK pharmteco
11.17.1 SK pharmteco Company Information
11.17.2 SK pharmteco Cell Therapy CDMO Services Product Offered
11.17.3 SK pharmteco Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 SK pharmteco Main Business Overview
11.17.5 SK pharmteco Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.